Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · February 27, 2023

Dose Adjustments of Elexacaftor/Tezacaftor/Ivacaftor in Response to Mental Health Side Effects in Adults With Cystic Fibrosis

Journal of Cystic Fibrosis


Additional Info

Journal of Cystic Fibrosis
Dose adjustments of Elexacaftor/Tezacaftor/Ivacaftor in response to mental health side effects in adults with cystic fibrosis
J Cyst Fibros 2022 Nov 01;21(6)1061-1065, G Spoletini, L Gillgrass, K Pollard, N Shaw, E Williams, C Etherington, IJ Clifton, DG Peckham

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading